Holdings

Profund Vp Pharmaceuticals

As of Jun 30, 2026, Profund Vp Pharmaceuticals reported 65 positions worth US$11.2M. Largest: Definium Therapeutics, Inc., MBX Biosciences, Inc. and Alumis Inc. What it bought and sold, with each filing.

Holdings

Positions
65
Value as reported
US$11.2M
Holdings as of
Jun 30, 2026
Last filed
Aug 28, 2026
CompanySharesValue as reported% of portfolioChangeAs of
Definium Therapeutics, Inc.
NASDAQ:DFTX
7,334US$345K3.0%−2,719Jun 30, 2026
MBX Biosciences, Inc.
NASDAQ:MBX
5,500US$304K2.6%−869Jun 30, 2026
Alumis Inc.
NASDAQ:ALMS
8,497US$239K2.1%+1,387Jun 30, 2026
AtaiBeckley Inc.
NASDAQ:ATAI
45,092US$238K2.1%NewJun 30, 2026
Trevi Therapeutics, Inc.
NASDAQ:TRVI
12,720US$237K2.1%−2,966Jun 30, 2026
Enliven Therapeutics, Inc.
NASDAQ:ELVN
4,607US$234K2.0%−1,494Jun 30, 2026
Amylyx Pharmaceuticals, Inc.
NASDAQ:AMLX
12,663US$227K2.0%+119Jun 30, 2026
Veradermics, Incorporated
NYSE:MANE
1,833US$225K2.0%NewJun 30, 2026
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
687US$217K1.9%−160Jun 30, 2026
Nuvation Bio Inc.
NYSE:NUVB
37,216US$211K1.8%−3,587Jun 30, 2026
Edgewise Therapeutics, Inc.
NASDAQ:EWTX
5,178US$210K1.8%−865Jun 30, 2026
Nektar Therapeutics
NASDAQ:NKTR
3,002US$210K1.8%+448Jun 30, 2026
Liquidia Corporation
NASDAQ:LQDA
2,612US$208K1.8%−2,245Jun 30, 2026
Maze Therapeutics, Inc.
NASDAQ:MAZE
6,930US$207K1.8%+3,217Jun 30, 2026
Harrow, Inc.
NASDAQ:HROW
4,748US$202K1.8%−322Jun 30, 2026
EyePoint, Inc.
NASDAQ:EYPT
13,824US$198K1.7%+1,271Jun 30, 2026
Amneal Pharmaceuticals, Inc.
NASDAQ:AMRX
11,126US$193K1.7%−3,609Jun 30, 2026
Ocular Therapeutix, Inc.
NASDAQ:OCUL
19,502US$192K1.7%−213Jun 30, 2026
Corcept Therapeutics Incorporated
NASDAQ:CORT
2,182US$190K1.6%−3,369Jun 30, 2026
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
4,965US$186K1.6%−100Jun 30, 2026
Pacira BioSciences, Inc.
NASDAQ:PCRX
7,278US$185K1.6%−926Jun 30, 2026
Merck & Company, Inc.
NYSE:MRK
1,431US$184K1.6%−181Jun 30, 2026
Indivior Pharmaceuticals, Inc.
NASDAQ:INDV
4,475US$184K1.6%−1,230Jun 30, 2026
Elanco Animal Health Incorporated
NYSE:ELAN
7,453US$183K1.6%−534Jun 30, 2026
Johnson & Johnson
NYSE:JNJ
715US$182K1.6%−56Jun 30, 2026
Eli Lilly and Company
NYSE:LLY
150US$180K1.6%−37Jun 30, 2026
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
742US$179K1.6%−268Jun 30, 2026
Collegium Pharmaceutical, Inc.
NASDAQ:COLL
4,898US$177K1.5%−360Jun 30, 2026
Bristol-Myers Squibb Company
NYSE:BMY
3,066US$177K1.5%−57Jun 30, 2026
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
3,780US$176K1.5%+261Jun 30, 2026
Royalty Pharma plc
NASDAQ:RPRX
3,127US$175K1.5%−884Jun 30, 2026
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
2,782US$175K1.5%+102Jun 30, 2026
Wave Life Sciences Ltd.
NASDAQ:WVE
30,115US$175K1.5%+16,813Jun 30, 2026
Harmony Biosciences Holdings, Inc.
NASDAQ:HRMY
4,804US$175K1.5%−1,701Jun 30, 2026
ANI Pharmaceuticals, Inc.
NASDAQ:ANIP
2,084US$173K1.5%−371Jun 30, 2026
Organon & Co.
NYSE:OGN
12,739US$172K1.5%−16,525Jun 30, 2026
Viatris Inc.
NASDAQ:VTRS
10,808US$172K1.5%−2,598Jun 30, 2026
Esperion Therapeutics, Inc.
NASDAQ:ESPR
54,283US$172K1.5%−15,347Jun 30, 2026
Axsome Therapeutics, Inc.
NASDAQ:AXSM
692US$169K1.5%−482Jun 30, 2026
Innoviva, Inc.
NASDAQ:INVA
7,411US$168K1.5%−943Jun 30, 2026
BioAge Labs, Inc.
NASDAQ:BIOA
6,835US$168K1.5%+142Jun 30, 2026
Prestige Consumer Healthcare Inc.
NYSE:PBH
3,469US$164K1.4%+579Jun 30, 2026
Rapport Therapeutics, Inc.
NASDAQ:RAPP
3,855US$161K1.4%−412Jun 30, 2026
Pfizer, Inc.
NYSE:PFE
6,658US$160K1.4%−202Jun 30, 2026
Omeros Corporation
NASDAQ:OMER
16,711US$159K1.4%+1,012Jun 30, 2026
Perrigo Company plc
NYSE:PRGO
15,260US$159K1.4%−3,832Jun 30, 2026
Xeris Biopharma Holdings, Inc.
NASDAQ:XERS
19,640US$156K1.4%−11,312Jun 30, 2026
Zoetis Inc.
NYSE:ZTS
2,097US$151K1.3%+534Jun 30, 2026
Eton Pharmaceuticals, Inc.
NASDAQ:ETON
4,026US$146K1.3%NewJun 30, 2026
Phibro Animal Health Corporation
NASDAQ:PAHC
4,568US$143K1.2%+1,407Jun 30, 2026
Amphastar Pharmaceuticals, Inc.
NASDAQ:AMPH
6,925US$140K1.2%−298Jun 30, 2026
Arvinas, Inc.
NASDAQ:ARVN
16,762US$139K1.2%+5,275Jun 30, 2026
Zevra Therapeutics, Inc.
NASDAQ:ZVRA
9,630US$138K1.2%−677Jun 30, 2026
Alto Neuroscience, Inc.
NYSE:ANRO
4,959US$131K1.1%+2,634Jun 30, 2026
Phathom Pharmaceuticals, Inc.
NASDAQ:PHAT
10,944US$119K1.0%−1,711Jun 30, 2026
Relmada Therapeutics, Inc.
NASDAQ:RLMD
17,078US$118K1.0%NewJun 30, 2026
CorMedix Inc.
NASDAQ:CRMD
14,334US$113K0.98%−3,251Jun 30, 2026
Septerna, Inc.
NASDAQ:SEPN
3,303US$111K0.96%−778Jun 30, 2026
Theravance Biopharma, Inc.
NASDAQ:TBPH
6,286US$107K0.93%−2,242Jun 30, 2026
Aclaris Therapeutics, Inc.
NASDAQ:ACRS
18,874US$99,8430.87%NewJun 30, 2026
LB Pharmaceuticals Inc
NASDAQ:LBRX
2,742US$88,9920.77%−88Jun 30, 2026
Aquestive Therapeutics, Inc.
NASDAQ:AQST
20,535US$85,4260.74%+1,490Jun 30, 2026
Fulcrum Therapeutics, Inc.
NASDAQ:FULC
21,055US$77,0610.67%+9,389Jun 30, 2026
Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
29,252US$70,2050.61%NewJun 30, 2026
Evolus, Inc. Common Stock
NASDAQ:EOLS
8,464US$58,7400.51%NewJun 30, 2026